1 recruiting. .
Follow Apixaban 2.5 mg BID: new trials by email Literature Review of Apixaban 2.5 mg BID trials Research Report on Apixaban 2.5 mg BID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention Left Atrial Appendage Closure, Apixaban 2.5 mg BID, Standard-dose DOAC - Atrial Fibrillation, Stroke Prevention in Patients With Atrial Fibrillation | Recruiting | National Medical Research Center for Therapy and Preventive Medicine | 464 | 2026-04-01 | 2026-05-08 |
Atrial Fibrillation (1) · Hemorrhage (1) · Thromboembolism (1)
National Medical Research Center for Therapy and Preventive Medicine (1)
Russia (1)